amfAR Praises PEPFAR Reauthorization, Yet Concerns Over One-Year Authorization and Implications for U.S. Global Health Leadership Remain
New amfAR Fellowships Support Innovative Research on Antibodies, Treatment Interruption, and Aging and HIV